Invasive FFR and Noninvasive CFR in the Evaluation of Ischemia: What Is the Future?

Journal of the American College of Cardiology

Volumn 67, Issue 23, 2016, Pages 2772-2788

  Johnson, Nils P ^a   Gould, K Lance ^a   Di Carli, Marcelo F ^b   Taqueti, Viviany R ^b  

^a MEMORIAL HERMANN HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

coronary flow reserve; coronary physiology; fractional flow reserve

Indexed keywords

ACUTE CORONARY SYNDROME; ANGINA PECTORIS; ATHEROSCLEROSIS; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR MORTALITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY ARTERY OBSTRUCTION; CORONARY FLOW RESERVE; DISEASE SEVERITY; FRACTIONAL FLOW RESERVE; HEART MUSCLE REVASCULARIZATION; HUMAN; ISCHEMIA; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TREATMENT OUTCOME; ANGINA, STABLE; CORONARY STENOSIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; VASCULAR RESISTANCE;

ACUTE CORONARY SYNDROME; ANGINA, STABLE; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY STENOSIS; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VASCULAR RESISTANCE;

EID: 84978043037     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2016.03.584     Document Type: Review

References (100)

1. 1 Arbab-Zadeh, A., Nakano, M., Virmani, R., et al. Acute coronary events. Circulation 125 (2012), 1147–1156.
2. 2 Arbab-Zadeh, A., Fuster, V., The myth of the “vulnerable plaque”: transitioning from a focus on individual lesions to atherosclerotic disease burden for coronary artery disease risk assessment. J Am Coll Cardiol 65 (2015), 846–855.
3. 3 Virmani, R., Are our tools for the identification of TCFA ready and do we know them?. J Am Coll Cardiol Img 4 (2011), 656–658.
4. 4 Tian, J., Ren, X., Vergallo, R., et al. Distinct morphological features of ruptured culprit plaque for acute coronary events compared to those with silent rupture and thin-cap fibroatheroma: a combined optical coherence tomography and intravascular ultrasound study. J Am Coll Cardiol 63 (2014), 2209–2216.
5. 5 Gould, K.L., Johnson, N.P., Kaul, S., et al. Patient selection for elective revascularization to reduce myocardial infarction and mortality: new lessons from randomized trials, coronary physiology, and statistics. Circ Cardiovasc Imaging, 8, 2015 e003099.
6. 6 Choi, G., Lee, J.M., Kim, H.J., et al. Coronary artery axial plaque stress and its relationship with lesion geometry: application of computational fluid dynamics to coronary CT angiography. J Am Coll Cardiol Img 8 (2015), 1156–1166.
7. 7 Young, L.H., Wackers, F.J., Chyun, D.A., et al., for the DIAD Investigators. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. JAMA 301 (2009), 1547–1555.
8. 8 Hachamovitch, R., Nutter, B., Hlatky, M.A., et al., for the SPARC Investigators. Patient management after noninvasive cardiac imaging: results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease). J Am Coll Cardiol 59 (2012), 462–474.
9. 9 Hermann, L.K., Newman, D.H., Pleasant, W.A., et al. Yield of routine provocative cardiac testing among patients in an emergency department-based chest pain unit. JAMA Intern Med 173 (2013), 1128–1133.
10. 10 The ISCHEMIA Study. 2016. Available at: https://www.ischemiatrial.org/. Accessed April 8, 2016.
11. 11 Stone, G.W., Maehara, A., Lansky, A.J., et al., for the PROSPECT Investigators. A prospective natural-history study of coronary atherosclerosis. [erratum in: N Engl J Med 2011;365:2040] N Engl J Med 364 (2011), 226–235.
12. 12 Fox, K.A.A., Clayton, T.C., Damman, P., et al., for the FIR Collaboration. Long-term outcome of a routine versus selective invasive strategy in patients with non–ST-segment elevation acute coronary syndrome: a meta-analysis of individual patient data. J Am Coll Cardiol 55 (2010), 2435–2445.
13. 13 Dehmer, G.J., Weaver, D., Roe, M.T., et al. A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. J Am Coll Cardiol 60 (2012), 2017–2031.
14. 14 Fokkema, M.L., James, S.K., Albertsson, P., et al. Population trends in percutaneous coronary intervention: 20-year results from the SCAAR (Swedish Coronary Angiography and Angioplasty Registry). J Am Coll Cardiol 61 (2013), 1222–1230.
15. 15 Thygesen, K., Alpert, J.S., Jaffe, A.S., et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 60 (2012), 1581–1598.
16. 16 Authors/Task Force Members, Steg, P.G., James, S.K., et al. ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33 (2012), 2569–2619.
17. 17 O'Gara, P.T., Kushner, F.G., Ascheim, D.D., et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 61 (2013), e78–e140.
18. 18 Johnson, N.P., Kirkeeide, R.L., Gould, K.L., History and development of coronary flow reserve (CFR) and fractional flow reserve (FFR) for clinical application. Intervent Cardiol Clin 4 (2015), 397–410.
19. 19 Koolen, J.J., Pijls, N.H., Coronary pressure never lies. Catheter Cardiovasc Interv 72 (2008), 248–256.
20. 20 Lee, B.K., Lim, H.S., Fearon, W.F., et al. Invasive evaluation of patients with angina in the absence of obstructive coronary artery disease. Circulation 131 (2015), 1054–1060.
21. 21 Layland, J., Oldroyd, K.G., Curzen, N., et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J 36 (2015), 100–111.
22. 22 Fearon, W.F., Low, A.F., Yong, A.S., et al. Prognostic value of the Index of Microcirculatory Resistance measured after primary percutaneous coronary intervention. Circulation 127 (2013), 2436–2441.
23. 23 Jin, X., Yoon, M.H., Seo, K.W., et al. Usefulness of hyperemic microvascular resistance index as a predictor of clinical outcomes in patients with ST-segment elevation myocardial infarction. Korean Circ J 45 (2015), 194–201.
24. 24 Cuculi, F., De Maria, G.L., Meier, P., et al. Impact of microvascular obstruction on the assessment of coronary flow reserve, index of microcirculatory resistance, and fractional flow reserve after ST-segment elevation myocardial infarction. J Am Coll Cardiol 64 (2014), 1894–1904.
25. 25 Meuwissen, M., Chamuleau, S.A., Siebes, M., et al. Role of variability in microvascular resistance on fractional flow reserve and coronary blood flow velocity reserve in intermediate coronary lesions. Circulation 103 (2001), 184–187.
26. 26 Fearon, W.F., Balsam, L.B., Farouque, H.M., et al. Novel index for invasively assessing the coronary microcirculation. Circulation 107 (2003), 3129–3132.
27. 27 Kitabata, H., Kubo, T., Ishibashi, K., et al. Prognostic value of microvascular resistance index immediately after primary percutaneous coronary intervention on left ventricular remodeling in patients with reperfused anterior acute ST-segment elevation myocardial infarction. J Am Coll Cardiol Intv 6 (2013), 1046–1054.
28. 28 Hennigan, B., Layland, J., Fearon, W.F., et al. Fractional flow reserve and the index of microvascular resistance in patients with acute coronary syndromes. EuroIntervention 10:Suppl T (2014), T55–T63.
29. 29 Ahn, S.G., Lee, S.H., Lee, J.H., et al. Efficacy of combination treatment with intracoronary abciximab and aspiration thrombectomy on myocardial perfusion in patients with ST-segment elevation myocardial infarction undergoing primary coronary stenting. Yonsei Med J 55 (2014), 606–616.
30. 30 Hoole, S.P., Jaworski, C., Brown, A.J., et al. Serial assessment of the index of microcirculatory resistance during primary percutaneous coronary intervention comparing manual aspiration catheter thrombectomy with balloon angioplasty (IMPACT study): a randomised controlled pilot study. Open Heart, 2, 2015 e000238.
31. 31 Clinical Centre of Serbia. Physiologic Assessment of Thrombus Aspiration in Acute ST-segment Elevation Myocardial Infarction Patients (PATA-STEMI). 2013. Available at: https://clinicaltrials.gov/ct2/show/NCT01824641. Accessed April 1, 2016.
32. 32 Kostic, J., Djordjevic-Dikic, A., Dobric, M., et al. The effects of nicorandil on microvascular function in patients with ST segment elevation myocardial infarction undergoing primary PCI. Cardiovasc Ultrasound, 13, 2015, 26.
33. 33 Inha University Hospital. Comparison of clopidogrel and ticagrelor on microvascular dysfunction in acute coronary syndrome patients. 2015. Available at: https://clinicaltrials.gov/ct2/show/NCT02026219. Accessed April 1, 2016.
34. 34 Wald, D.S., Morris, J.K., Wald, N.J., et al., for the PRAMI Investigators. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 369 (2013), 1115–1123.
35. 35 Gershlick, A.H., Khan, J.N., Kelly, D.J., et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 65 (2015), 963–972.
36. 36 Engstrøm, T., Kelbæk, H., Helqvist, S., et al., for the DANAMI-3—PRIMULTI Investigators. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial. Lancet 386 (2015), 665–671.
37. 37 Population Health Research Institute. Complete vs Culprit-only Revascularization to Treat Multi-vessel Disease After Primary PCI for STEMI (COMPLETE). 2015. Available at: https://clinicaltrials.gov/ct2/show/NCT01740479. Accessed April 1, 2016.
38. 38 Smits, P.C., Vlachojannis, G.J., Lunde, K., et al. TCT-328: FFR-guided complete revascularization during primary PCI: preliminary data from the COMPARE ACUTE trial (abstr). J Am Coll Cardiol, 64(Suppl 11), 2014, B95.
39. 39 Sels, J.W., Tonino, P.A., Siebert, U., et al. Fractional flow reserve in unstable angina and non-ST-segment elevation myocardial infarction: experience from the FAME (Fractional flow reserve versus Angiography for Multivessel Evaluation) study. J Am Coll Cardiol Intv 4 (2011), 1183–1189.
40. 40 Ntalianis, A., Sels, J.W., Davidavicius, G., et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. J Am Coll Cardiol Intv 3 (2010), 1274–1281.
41. 41 Layland, J., Carrick, D., McEntegart, M., et al. Vasodilatory capacity of the coronary microcirculation is preserved in selected patients with non-ST-segment-elevation myocardial infarction. Circ Cardiovasc Interv 6 (2013), 231–236.
42. 42 Maastad Hospital. Comparison Between FFR Guided Revascularization Versus Conventional Strategy in Acute STEMI Patients With MVD. (CompareAcute). 2015. Available at: https://clinicaltrials.gov/ct2/show/NCT01399736. Accessed April 1, 2016.
43. 43 Toth, G., Hamilos, M., Pyxaras, S., et al. Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses. Eur Heart J 35 (2014), 2831–2838.
44. 44 Mozaffarian, D., Benjamin, E.J., Go, A.S., et al., for the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 131 (2015), e29–e322.
45. 45 Levine, G.N., Bates, E.R., Blankenship, J.C., et al. 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention. a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions. J Am Coll Cardiol 58 (2011), e44–e122.
46. 46 Rothberg, M.B., Sivalingam, S.K., Kleppel, R., et al. Informed decision making for percutaneous coronary intervention for stable coronary disease. JAMA Intern Med 175 (2015), 1199–1206.
47. 47 Johnson, N.P., Tóth, G.G., Lai, D., et al. Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes. J Am Coll Cardiol 64 (2014), 1641–1654.
48. 48 Gould, K.L., Johnson, N.P., Bateman, T.M., et al. Anatomic versus physiologic assessment of coronary artery disease: role of coronary flow reserve, fractional flow reserve, and positron emission tomography imaging in revascularization decision-making. J Am Coll Cardiol 62 (2013), 1639–1653.
49. 49 Pijls, N.H., De Bruyne, B., Peels, K., et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. N Engl J Med 334 (1996), 1703–1708.
50. 50 Depta, J.P., Patel, J.S., Novak, E., et al. Risk model for estimating the 1-year risk of deferred lesion intervention following deferred revascularization after fractional flow reserve assessment. Eur Heart J 36 (2015), 509–515.
51. 51 Barbato, E., Toth, G., Pijls, N.H.J., et al. P3978: actual FFR value predicts natural history of stenoses in patients with stable coronary disease. A FAME 2 trial subanalysis (abstr). Eur Heart J, 34, 2013, 716.
52. 52 Park SJ. Natural History of FFR Guided Deferred Coronary Lesions (IRIS FFR). 2016. Available at: https://clinicaltrials.gov/ct2/show/NCT01366404. Accessed April 1, 2016.
53. 53 Park SJ. Fate of deferred lesion: insight from prospective IRIS-FFR registry. Presented at: TCTAP 2015; April 29, 2015; Seoul, Korea.
54. 54 Adjedj J, De Bruyne B, Floré V, et al. Euro15A-OP021: FFR grey zone and clinical outcome. Presented at: EuroPCR 2015; May 22, 2015; Paris, France.
55. 55 Herzog, B.A., Husmann, L., Valenta, I., et al. Long-term prognostic value of 13N-ammonia myocardial perfusion positron emission tomography added value of coronary flow reserve. J Am Coll Cardiol 54 (2009), 150–156.
56. 56 Ziadi, M.C., Dekemp, R.A., Williams, K.A., et al. Impaired myocardial flow reserve on rubidium-82 positron emission tomography imaging predicts adverse outcomes in patients assessed for myocardial ischemia. J Am Coll Cardiol 58 (2011), 740–748.
57. 82Rb PET perfusion imaging. J Nucl Med 52 (2011), 726–732.
58. 58 Wang, L., Jerosch-Herold, M., Jacobs, D.R. Jr., et al. Coronary risk factors and myocardial perfusion in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA). J Am Coll Cardiol 47 (2006), 565–572.
59. 59 Murthy, V.L., Naya, M., Foster, C.R., et al. Improved cardiac risk assessment with noninvasive measures of coronary flow reserve. Circulation 124 (2011), 2215–2224.
60. 60 Murthy, V.L., Naya, M., Foster, C.R., et al. Association between coronary vascular dysfunction and cardiac mortality in patients with and without diabetes mellitus. Circulation 126 (2012), 1858–1868.
61. 61 Taqueti, V.R., Hachamovitch, R., Murthy, V.L., et al. Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 131 (2015), 19–27.
62. 62 van de Hoef, T.P., van Lavieren, M.A., Damman, P., et al. Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circ Cardiovasc Interv 7 (2014), 301–311.
63. 63 Johnson, N.P., Kirkeeide, R.L., Gould, K.L., Is discordance of coronary flow reserve and fractional flow reserve due to methodology or clinically relevant coronary pathophysiology?. J Am Coll Cardiol Img 5 (2012), 193–202.
64. 64 University of Texas Health Science Center, Houston. Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses (DEFINE-FLOW). 2014. Available at: https://clinicaltrials.gov/ct2/show/NCT02328820. Accessed April 1, 2016.
65. 65 Rothberg, M.B., Sivalingam, S.K., Ashraf, J., et al. Patients' and cardiologists' perceptions of the benefits of percutaneous coronary intervention for stable coronary disease. Ann Intern Med 153 (2010), 307–313.
66. 66 De Bruyne, B., Fearon, W.F., Pijls, N.H., et al., for the FAME 2 Trial Investigators. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371 (2014), 1208–1217.
67. 67 Hueb, W., Lopes, N.H., Gersh, B.J., et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation 115 (2007), 1082–1089.
68. 68 BARI 2D Study Group. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med 360 (2009), 2503–2515.
69. 69 Boden, W.E., O'Rourke, R.A., Teo, K.K., et al., for the COURAGE Trial Research Group. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med 356 (2007), 1503–1516.
70. 70 Escaned, J., Echavarría-Pinto, M., Garcia-Garcia, H.M., et al., for the ADVISE II Study Group. Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II). J Am Coll Cardiol Intv 8 (2015), 824–833.
71. 2O PET imaging. J Am Coll Cardiol 64 (2014), 1464–1475.
72. 72 Li, M., Zhou, T., Yang, L.F., et al. Diagnostic accuracy of myocardial magnetic resonance perfusion to diagnose ischemic stenosis with fractional flow reserve as reference: systematic review and meta-analysis. J Am Coll Cardiol Img 7 (2014), 1098–1105.
73. 73 Li, S., Tang, X., Peng, L., et al. The diagnostic performance of CT-derived fractional flow reserve for evaluation of myocardial ischaemia confirmed by invasive fractional flow reserve: a meta-analysis. Clin Radiol 70 (2015), 476–486.
74. 74 Blankenship, J.C., Marshall, J.J., Pinto, D.S., et al. Effect of percutaneous coronary intervention on quality of life: a consensus statement from the Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 81 (2013), 243–259.
75. 75 Mauri, L., Kereiakes, D.J., Yeh, R.W., et al., for the DAPT Study Investigators. Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med 371 (2014), 2155–2166.
76. 76 Mohr, F.W., Morice, M.C., Kappetein, A.P., et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 381 (2013), 629–638.
77. 77 Gould, K.L., Johnson, N.P., Physiologic severity of diffuse coronary artery disease: hidden high risk. Circulation 131 (2015), 4–6.
78. 78 Pijls, N.H., van Schaardenburgh, P., Manoharan, G., et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. J Am Coll Cardiol 49 (2007), 2105–2111.
79. 79 van Nunen, L.X., Zimmermann, F.M., Tonino, P.A., et al., for the FAME Study Investigators. Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial. Lancet 386 (2015), 1853–1860.
80. 80 De Bruyne, B., Hersbach, F., Pijls, N.H., et al. Abnormal epicardial coronary resistance in patients with diffuse atherosclerosis but “normal” coronary angiography. Circulation 104 (2001), 2401–2406.
81. 81 Hoffmann, U., Truong, Q.A., Schoenfeld, D.A., et al., for the ROMICAT-II Investigators. Coronary CT angiography versus standard evaluation in acute chest pain. N Engl J Med 367 (2012), 299–308.
82. 82 Douglas, P.S., Hoffmann, U., Patel, M.R., et al., for the PROMISE Investigators. Outcomes of anatomical versus functional testing for coronary artery disease. N Engl J Med 372 (2015), 1291–1300.
83. 83 King, S.B. III, Dickert, N.W., Miller, F.G., Learning from FAME: the need for sham controls in trials of stable coronary disease. J Am Coll Cardiol Intv 7 (2014), 342–344.
84. 84 Imperial College London. Comparison of Coronary Angioplasty and Optimum Medical Therapy Versus Optimal Medical Therapy in the Stable Angina (ORBITA). 2016. Available at: https://clinicaltrials.gov/ct2/show/NCT02062593. Accessed April 1, 2016.
85. 85 Johnson, N.P., Gould, K.L., Physiological basis for angina and ST-segment change PET-verified thresholds of quantitative stress myocardial perfusion and coronary flow reserve. J Am Coll Cardiol Img 4 (2011), 990–998.
86. 86 Johnson, N.P., Kirkeeide, R.L., Gould, K.L., Coronary anatomy to predict physiology: fundamental limits. Circ Cardiovasc Imaging 6 (2013), 817–832.
87. 87 Koo, B.K., Erglis, A., Doh, J.H., et al. Diagnosis of ischemia-causing coronary stenoses by noninvasive fractional flow reserve computed from coronary computed tomographic angiograms: results from the prospective multicenter DISCOVER-FLOW (Diagnosis of Ischemia-Causing Stenoses Obtained Via Noninvasive Fractional Flow Reserve) study. J Am Coll Cardiol 58 (2011), 1989–1997.
88. 88 Min, J.K., Leipsic, J., Pencina, M.J., et al. Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA 308 (2012), 1237–1245.
89. 89 Nørgaard, B.L., Leipsic, J., Gaur, S., et al., for the NXT Trial Study Group. Diagnostic performance of noninvasive fractional flow reserve derived from coronary computed tomography angiography in suspected coronary artery disease: the NXT trial (Analysis of Coronary Blood Flow Using CT Angiography: Next Steps). J Am Coll Cardiol 63 (2014), 1145–1155.
90. 90 Jeremias, A., Maehara, A., Généreux, P., et al. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. J Am Coll Cardiol 63 (2014), 1253–1261.
91. 91 Echavarría-Pinto, M., van de Hoef, T.P., Garcia-Garcia, H.M., et al., for the ADVISE II Study Group. Diagnostic accuracy of baseline distal-to-aortic pressure ratio to assess coronary stenosis severity: a post-hoc analysis of the ADVISE II Study. J Am Coll Cardiol Intv 8 (2015), 834–836.
92. 92 Schindler, T.H., Schelbert, H.H., Mismatch” in regional myocardial perfusion defects during exercise and pharmacologic vasodilation: a noninvasive marker of epicardial vasomotor dysfunction?. J Nucl Cardiol 14 (2007), 769–774.
93. 93 Jespersen, L., Hvelplund, A., Abildstrøm, S.Z., et al. Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33 (2012), 734–744.
94. 94 Pepine, C.J., Anderson, R.D., Sharaf, B.L., et al. Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia: results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol 55 (2010), 2825–2832.
95. 95 Murthy, V.L., Naya, M., Taqueti, V.R., et al. Effects of sex on coronary microvascular dysfunction and cardiac outcomes. Circulation 129 (2014), 2518–2527.
96. 96 Lin, S., Tremmel, J.A., Yamada, R., et al. A novel stress echocardiography pattern for myocardial bridge with invasive structural and hemodynamic correlation. J Am Heart Assoc, 2, 2013, e000097.
97. 97 Wei, J., Mehta, P.K., Johnson, B.D., et al. Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll Cardiol Intv 5 (2012), 646–653.
98. 98 Johnson, N.P., Johnson, D.T., Kirkeeide, R.L., et al. Repeatability of fractional flow reserve despite variations in systemic and coronary hemodynamics. J Am Coll Cardiol Intv 8 (2015), 1018–1027.
99. 99 Johnson, N.P., Gould, K.L., Integrating noninvasive absolute flow, coronary flow reserve, and ischemic thresholds into a comprehensive map of physiological severity. J Am Coll Cardiol Img 5 (2012), 430–440.
100. 100 Gould, K.L., Kirkeeide, R., Johnson, N.P., Coronary branch steal: experimental validation and clinical implications of interacting stenosis in branching coronary arteries. Circ Cardiovasc Imaging 3 (2010), 701–709.